Cite
HARVARD Citation
Zhaohu, H. et al. (2022). Efficacy and Safety of Dapagliflozin versus Liraglutide in Patients with Overweight or Obesity and Type 2 Diabetes Mellitus: A Randomised Controlled Clinical Trial in Tianjin, China. Journal of diabetes research. p. . [Online].